dendrit
cellspecif
intercellular
adhes
moleculegrab
nonintegrinrel
protein
dcsignr
type
ii
transmembran
protein
report
bind
varieti
pathogen
well
particip
immunoregul
associ
level
dcsignr
lung
cancer
unknown
investig
clinic
diagnost
signific
dcsignr
lung
cancer
investig
serum
dcsignr
level
lung
cancer
patient
healthi
individu
use
enzymelink
immunosorb
assay
elisa
result
show
serum
dcsignr
level
lung
cancer
patient
lower
healthi
control
p
cutoff
valu
ngl
dcsignr
predict
presenc
lung
cancer
sensit
specif
area
curv
p
strikingli
serum
dcsignr
level
significantli
higher
lung
cancer
patient
brain
metastasi
compar
without
metastasi
p
moreov
serum
concentr
dcsignr
lung
cancer
patient
also
correl
significantli
serum
natur
killer
cell
percentag
p
addit
immunohistochemistri
assay
demonstr
express
dcsignr
lung
tissu
lung
cancer
patient
tuberculosi
patient
significantli
lower
normal
lung
tissu
p
signific
differ
tuberculosi
tissu
lung
cancer
tissu
p
result
suggest
dcsignr
mayb
promis
biolog
molecul
potenti
clinic
research
lung
cancer
wherea
underli
role
need
investig
studi
lung
cancer
lead
caus
cancer
death
worldwid
among
men
second
lead
cancer
site
women
high
mortal
rate
diseas
primarili
due
difficulti
earli
diagnosi
high
metastat
potenti
poor
respons
chemic
therapi
radiotherapi
unfortun
unclear
etiolog
lung
cancer
present
huge
challeng
treatment
lung
cancer
mani
group
result
show
smoke
import
modifi
risk
factor
lung
cancer
otherwis
lung
cancer
suscept
also
determin
host
genet
factor
infect
may
play
role
lung
cancer
includ
human
papilloma
viru
ppv
epsteinbarr
viru
human
immunodefici
viru
hiv
addit
biolog
molecul
correl
risk
lung
cancer
pselectin
chondrolectin
chodl
known
risk
factor
lung
cancer
includ
exposur
electron
supplementari
materi
onlin
version
articl
contain
supplementari
materi
avail
author
user
sever
occup
environment
carcinogen
asbesto
arsen
polycycl
aromat
hydrocarbon
recent
studi
sever
group
suggest
lectin
may
play
import
role
varieti
physiolog
patholog
process
typic
tumor
progress
metastasi
exampl
borsig
report
selectin
upregul
pulmonari
metastat
microenviron
facilit
p
lselectin
mediat
interact
tumor
cell
blood
compon
significantli
reduc
metastasi
group
result
also
show
high
mannosebind
lectin
mbl
level
associ
poorer
lung
cancer
surviv
low
mbl
level
increas
gastric
cancer
risk
addit
liver
sinusoid
endotheli
cell
lectin
lsectin
adher
colorect
cell
play
import
role
colorect
carcinoma
liver
metastasi
recent
laboratori
report
dcsign
dcsignr
low
express
patient
nonhodgkin
lymphoma
nhl
could
potenti
use
nhl
clinic
set
dcsign
dcsignr
novel
bloodbas
molecular
marker
potenti
use
diagnosi
earli
stage
colon
cancer
patient
therefor
interest
express
dcsignr
lung
cancer
patient
dcsignr
closest
homologu
ctype
lectin
superfamili
member
dcsign
lsectin
consist
ntermin
cytoplasm
tail
transmembran
domain
extracellular
ctermin
neck
region
ctype
carbohydr
recognit
domain
crd
crd
domain
dcsignr
interact
high
mannos
carbohydr
neck
domain
support
crd
may
influenc
ligandbind
properti
lectin
intracellular
domain
locat
cytoplasm
tail
contain
recycl
intern
motif
dcsignr
highli
express
liver
sinusoid
endotheli
cell
lymph
node
endotheli
cell
signific
proport
term
placenta
capillari
endotheli
cell
express
peripher
bloodderiv
dc
furthermor
dcsignr
also
express
lung
cytokeratin
posit
alveolar
epithelia
well
subset
cell
coexpress
angiotensin
convert
neg
cytokeratin
like
dcsign
dcsignr
recogn
bind
sever
pathogen
includ
virus
bacteria
fungi
parasit
dcsignr
also
recogn
endogen
ligand
icam
molecul
although
glycan
epitop
fulli
character
howev
role
dcsignr
lung
cancer
elucid
research
compar
serum
level
dcsignr
lung
cancer
patient
healthi
volunt
use
elisa
found
lung
cancer
patient
show
lower
level
dcsignr
compar
healthi
control
correl
serum
level
dcsignr
clinic
paramet
lung
cancer
patient
immunohistochemistri
ihc
studi
dcsignr
lower
express
lung
tissu
lung
cancer
patient
compar
normal
lung
tissu
serum
sampl
lung
cancer
patient
obtain
first
second
affili
hospit
dalian
medic
univers
march
store
analyz
mean
age
patient
year
rang
year
male
femal
accord
world
health
organ
classif
lung
cancer
case
consist
small
cell
lung
cancer
sclc
nonsmal
cell
lung
cancer
nsclc
nsclc
divid
three
major
patholog
subtyp
includ
adenocarcinoma
adc
squamou
cell
carcinoma
scc
larg
cell
carcinoma
clinic
stage
lung
cancer
patient
perform
accord
iaslc
lung
cancer
stage
clinic
data
includ
gender
age
cancer
stage
histolog
subtyp
concentr
tumor
marker
percentag
cell
subset
acquir
hospit
record
basic
characterist
subject
shown
tabl
supplementari
tabl
control
group
compos
healthi
blood
donor
volunt
among
healthi
subject
mean
age
year
rang
year
healthi
control
perform
routin
physic
examin
result
within
normal
rang
lung
cancer
patient
healthi
individu
variou
pathogen
infect
poor
perform
statu
exclud
present
studi
addit
formalinfix
paraffinembed
tissu
lung
cancer
patient
lung
tissu
tuberculosi
patient
normal
lung
tissu
lymph
node
obtain
second
affili
hospit
dalian
medic
univers
lung
tissu
tuberculosi
patient
normal
lung
tissu
use
control
group
normal
lymph
node
use
either
posit
neg
control
clinic
data
subject
summar
tabl
supplementari
tabl
use
standard
sandwich
elisa
detect
level
dcsignr
human
serum
micropl
coat
antidcsignr
goat
polyclon
antibodi
pab
santa
cruz
biotechnolog
inc
usa
catalog
number
final
concentr
lgml
incub
overnight
wash
plate
time
phosphat
buffer
salin
pb
contain
pbst
ph
well
block
block
buffer
bovin
serum
albumin
h
plate
wash
three
time
pbst
serum
lung
cancer
patient
healthi
control
ad
well
neg
control
pb
use
plate
incub
h
subsequ
pbst
use
wash
plate
time
antidcsignr
mous
monoclon
antibodi
mab
r
system
inc
usa
catalog
number
dilut
concentr
lgml
ad
well
plate
incub
h
wash
peroxidaseconjug
goat
antimous
zsgbbio
ad
plate
incub
h
final
plate
wash
time
incub
tetramethylbenzidin
tmb
tiangen
biotech
co
ltd
h
moll
h
ad
stop
reaction
optic
densiti
od
measur
nm
wavelength
micropl
reader
quantit
dcsignr
concentr
determin
compar
optic
densiti
valu
standard
curv
level
lung
cancer
patient
brain
metastasi
detect
elisa
kit
westang
biotech
ltd
patient
diseas
affect
level
exclud
studi
concentr
shown
supplementaryt
deparaffin
xylen
rehydr
grade
ethanol
seri
section
paraffinembed
block
incub
min
section
wash
pb
endogen
peroxidas
activ
block
hydrogen
peroxid
dilut
doubledistil
water
min
room
temperatur
antigen
retriev
perform
heat
slide
citrat
buffer
moll
citric
acid
ph
min
microwav
oven
wash
pb
section
incub
goat
serum
purpos
block
section
incub
antidcsignr
rabbit
pab
abcam
inc
overnight
next
day
wash
pb
section
incub
horseradish
peroxidaselabel
antirabbit
immunoglobulin
zsgbbio
h
wash
final
section
develop
diaminobenzidin
tetrahydrochlorid
dab
zsgbbio
within
cell
counterstain
hematoxylin
photograph
record
olympu
microscop
mean
densiti
dcsignr
express
assess
use
imagepro
plu
version
media
cybernet
inc
silver
spring
md
usa
integr
optic
densiti
iod
sum
repres
protein
content
dcsignr
area
interest
aoi
area
equal
area
aoi
iod
sum
area
stand
mean
densiti
briefli
imag
captur
magnif
aoiscas
select
base
area
maxim
dcsignr
stain
mean
densiti
valu
shown
supplementari
tabl
quantit
posit
correl
dcsignr
express
tissu
nonparametr
mannwhitney
u
test
use
determin
statist
signific
among
two
group
statist
signific
among
two
group
determin
kruskalw
nonparametr
test
correl
dcsignr
valu
clinic
paramet
test
nonparametr
spearman
rank
correl
coeffici
test
test
p
valu
consid
signific
statist
analys
perform
use
graphpad
graphpad
softwar
inc
san
diego
ca
usa
detect
serum
dcsignr
level
particip
compos
lung
cancer
healthi
control
elisa
dcsignr
level
serum
patient
lung
cancer
mgml
significantli
lower
healthi
control
mgml
p
fig
roc
curv
often
use
assess
power
novel
serum
marker
tumor
predict
present
studi
cutoff
valu
ngl
dcsignr
predict
presenc
lung
cancer
sensit
specif
area
curv
auc
p
fig
therefor
serum
dcsignr
level
demonstr
low
accuraci
detect
lung
cancer
serum
concentr
dcsignr
correl
significantli
lung
cancer
patient
brain
metastasi
assess
correl
serum
level
dcsignr
clinic
data
includ
gender
age
cancer
stage
histolog
subtyp
metastasi
differ
organ
strikingli
serum
concentr
dcsignr
lung
cancer
patient
brain
metastasi
higher
without
metastasi
p
fig
howev
level
dcsignr
patient
lung
cancer
show
signific
differ
metastasi
nonmetastasi
p
fig
furthermor
serum
dcsignr
level
significantli
differ
bone
metastasi
nonmetastasi
p
fig
lung
metastasi
nonmetastasi
p
fig
lymph
node
metastasi
nonmetastasi
p
fig
otherwis
found
serum
level
dcsignr
correl
significantli
serum
nk
cell
percentag
spearman
correl
coeffici
p
fig
howev
signific
correl
serum
dcsignr
spearman
correl
coeffici
p
fig
moreov
serum
level
dcsignr
show
associ
spearman
correl
coeffici
p
fig
addit
serum
level
dcsignr
display
correl
spearman
correl
coeffici
p
fig
signific
correl
observ
serum
level
dcsignr
clinic
paramet
age
gender
cancer
stage
histolog
subtyp
contrari
result
serum
level
dcsignr
patient
lung
cancer
show
signific
differ
male
femal
p
fig
serum
level
dcsignr
also
show
signific
differ
patient
year
old
patient
year
old
p
fig
serum
level
dcsignr
express
associ
age
spearman
correl
coeffici
p
fig
furthermor
serum
dcsignr
level
significantli
differ
among
stage
iii
stage
iiiiv
p
fig
addit
differ
histolog
subtyp
signific
differ
observ
lung
cancer
patient
sclc
nsclc
p
fig
similarli
differ
serum
dcsignr
level
appar
sclc
adc
scc
p
fig
serum
dcsignr
level
show
signific
correl
carcinoembryon
antigen
cea
neuronspecif
enolas
nse
studi
level
dcsignr
lung
cancer
patient
brain
metastasi
higher
without
metastasi
marker
brain
metastasi
compar
correl
two
molecular
howev
signific
correl
dcsignr
spearman
correl
coeffici
p
fig
present
studi
serum
level
dcsignr
express
associ
cea
spearman
correl
coeffici
p
fig
similarli
serum
level
dcsignr
significantli
correl
nse
spearman
correl
coeffici
p
fig
furthermor
data
also
show
correl
serum
dcsignr
level
spearman
correl
coeffici
p
fig
express
dcsignr
lung
cancer
patient
tuberculosi
patient
significantli
lower
normal
lung
tissu
determin
express
level
dcsignr
serum
moreov
report
dcsignr
fig
serum
dcsignr
level
significantli
correl
brain
metastasi
serum
level
dcsignr
significantli
differ
metastasi
nonmetastasi
p
serum
concentr
dcsignr
higher
brain
metastasi
nonmetastasi
p
b
howev
serum
dcsignr
level
significantli
differ
bone
metastasi
nonmetastasi
p
lung
metastasi
nonmetastasi
p
lymph
node
metastasi
nonmetastasi
p
b
mol
cell
biochem
express
lung
cytokeratin
posit
alveolar
epithelia
well
subset
cell
coexpress
therefor
want
know
whether
dcsignr
express
lung
cancer
tissu
perform
ihc
analysi
use
antidcsignr
pab
lung
cancer
tissu
sclc
adc
scc
lung
tissu
tuberculosi
patient
normal
lung
tissu
use
control
strikingli
mean
densiti
dcsignr
express
lung
cancer
patient
tuberculosi
patient
significantli
lower
normal
fig
normal
lymph
node
tumor
patient
use
posit
control
neg
control
express
dcsignr
mainli
occur
infect
diseas
acquir
immun
defici
syndrom
aid
hiv
infect
hepat
c
infect
diseas
ebola
viru
infect
diseas
recent
laboratori
report
dcsignr
express
lower
patient
nhl
healthi
individu
higher
express
colon
cancer
patient
serum
extend
knowledg
possibl
clinic
applic
dcsignr
studi
serum
level
dcsignr
patient
lung
cancer
also
studi
express
locat
level
dcsignr
lung
cancer
tissu
studi
demonstr
serum
level
dcsignr
lung
cancer
patient
significantli
lower
healthi
individu
furthermor
found
serum
dcsignr
level
correl
significantli
brain
metastasi
serum
nk
cell
percentag
lung
cancer
patient
brain
metastasi
one
dread
complic
lung
cancer
poor
prognosi
lung
cancer
patient
develop
brain
metastasi
cours
diseas
occurr
brain
metastasi
associ
poor
prognosi
high
morbid
patient
advanc
lung
cancer
even
intens
multimod
therapi
furthermor
littl
known
pathobiolog
molecular
mechan
involv
brain
metastat
cascad
limit
possibl
focus
drug
develop
clinic
trial
proapolipoprotein
serum
marker
brain
metastasi
lung
cancer
investig
recent
studi
studi
dcsignr
level
lung
cancer
patient
brain
metastasi
significantli
higher
without
metastasi
compar
correl
serum
dcsignr
level
howev
signific
correl
protein
found
astrocyt
releas
serum
bloodbrain
barrier
breach
express
dcsignr
brain
tissu
still
unknown
thu
guess
two
molecular
may
differ
mechan
affect
brain
metastasi
lung
cancer
investig
studi
also
compar
serum
level
dcsignr
bone
lung
lymph
node
metastasi
nonmetastasi
respect
found
signific
differ
natur
killer
nk
cell
major
compon
innat
immun
system
limit
growth
dissemin
sever
type
tumor
unlik
cell
b
cell
nk
cell
directli
exert
cellular
cytotox
tumor
cell
without
prior
sensit
secret
immunostimulatori
cytokin
control
local
tumor
growth
metastasi
epidemiolog
survey
show
low
nk
cell
activ
associ
increas
cancer
risk
numer
studi
demonstr
infiltr
nk
cell
appear
prognost
valu
gastric
carcinoma
colorect
carcinoma
lung
carcinoma
rel
higher
level
nk
cell
infiltr
correl
better
prognosi
thu
suggest
relev
protect
role
nk
cell
infiltr
present
studi
detect
significantli
neg
correl
serum
level
dcsignr
serum
percentag
nk
cell
lung
cancer
patient
molecular
mechan
neg
correl
yet
known
contrari
found
signific
correl
serum
level
dcsignr
serum
percentag
present
studi
order
know
dcsignr
whether
abil
distinguish
benign
malign
diseas
lung
choos
tuberculosi
tb
patient
result
mycobacterium
tuberculosi
infect
benign
diseas
group
mycobacterium
tuberculosi
target
dcsign
inhibit
immunostimulatori
function
dc
interact
mycobacteri
mannosyl
lipoarabinomannan
manlam
dcsign
like
dcsign
dcsignr
also
captur
manlam
rapidli
intern
lysosom
may
involv
clearanc
mycobacteria
tailleux
l
et
al
show
dcsign
present
alveolar
mu
lung
patient
tb
present
studi
found
dcsignr
express
lung
patient
tb
howev
significantli
differ
dcsignr
express
lung
cancer
tissu
tuberculosi
strikingli
lower
normal
lung
tissu
summari
shown
serum
level
dcsignr
promis
marker
help
distinguish
lung
cancer
patient
healthi
individu
addit
studi
warrant
assess
potenti
valu
dcsignr
vivo
studi
like
make
dcsignr
use
biolog
molecul
clinic
research
lung
cancer
mechan
futur
complianc
ethic
standard
studi
approv
research
ethic
committe
dalian
medic
univers
fig
ihc
dcsignr
express
tissu
lung
cancer
tissu
tuberculosi
patient
normal
tissu
ihc
analysi
use
determin
dcsignr
express
arrow
indic
posit
stain
area
black
box
c
e
g
enlarg
dcsignr
express
detect
lung
tissu
tuberculosi
patient
ab
dcsignr
express
detect
lung
tissu
lung
cancer
patient
cd
dcsignr
express
alveolar
epithelia
cell
normal
lung
tissu
ef
dcsignr
express
lymphat
endotheli
cell
exhibit
strong
posit
gh
normal
lymph
node
tissu
use
neg
control
ij
fig
semiquantit
imag
analysi
dcsignr
express
tissu
graph
display
scatter
plot
level
dcsignr
express
lung
tissu
lung
cancer
patient
tuberculosi
patient
normal
control
statist
signific
ihc
dcsignr
express
lung
cancer
tissu
normal
lung
tissu
p
tuberculosi
tissu
normal
control
p
significantli
differ
lung
cancer
patient
tuberculosi
patient
p
dcsignr
express
lung
cancer
patient
lower
normal
lung
tissu
inform
consent
obtain
particip
agreement
institut
guidelin
